Welcome to LiVDerm
Where the Constellations of Medical Dermatology and Aesthetics Collide
Led by world-renowned experts in the field, LiVDerm is a comprehensive dermatologic hub where medical professionals educate, collaborate, and engage.
LiVDerm’s mission is to boldly advance higher standards of dermatology care through live and virtual educational offerings, resources for providers, students and patients, and much more.
As a leading source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic dermatology, LiVDerm empowers providers to manage dermatologic conditions with confident authority. With a multipronged focus on the myriad specialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.
Upcoming Live Events
Complimentary Continuing Education
LivDerm Articles
FDA Approves First-Ever Topical Gene Therapy for Dystrophic Epidermolysis Bullosa
The FDA has approved Vyjuvek (beremagene geperpavec-svdt), for the treatment of dystrophic epidermolysis bullosa (DEB).
Study Reveals Gusacitinib is Well-Tolerated and Shows Rapid Improvement in Chronic Hand Eczema
Results from a phase 2 study of gusacitinib have demonstrated significant improvement in patients with chronic hand eczema.
FDA To Review New Drug Application for Triple-Combination IDP-126 Gel
The FDA has accepted the New Drug Application for investigational IDP-126 gel for the treatment of acne vulgaris.
Results Show Dupixent Meets Primary Endpoints for Treatment of Prurigo Nodularis in Adults
Two phase 3 trials evaluated the use of Dupixent (dupilumab) in the treatment of prurigo nodularis in adults.
FDA Approves Poly-L-Lactic Acid for Fine Line and Wrinkles in Cheeks
The FDA has approved Sculptra®, Galderma’s injectable poly-L-lactic acid to correct fine lines and wrinkles in the cheek area.
April W. Armstrong, MD, MPH Appointed Chief of the Division of Dermatology at UCLA Health
April W. Armstrong, MD, MPH appointed chief of the division of dermatology at University of California Health.
Tralokinumab Effective in Adolescents with Moderate-to-Severe Atopic Dermatitis
Tralokinumab clinical trial shows drug was well tolerated and efficacious in adolescents with moderate-to-severe atopic dermatitis (AD).
Patient Preferences in Topical Treatment for Psoriasis
Researchers sought to understand patient perspectives relating to their experience, expectations, and preferences of psoriasis treatment.
New Game-Changing Treatment for Hyperhidrosis Cleared by FDA
The FDA has cleared Candesant Biomedical’s Brella™, a SweatControl Patch for the treatment of primary axillary hyperhidrosis in adults.
FDA Accepts New Drug Application for Roflumilast Foam 0.3% for Seborrheic Dermatitis
Arcutis Biotherapeutics has announced the FDA has accepted their NDA for roflumilast foam 0.3% for the treatment of seborrheic dermatitis.
Recent Study Demonstrates Safety and Efficacy of Fixed Combination IDP-126
A randomized phase 2 study evaluated the safety, efficacy, and tolerability of IDP-126 in pediatric patients with moderate-to-severe acne.
Delphi Consensus Results: Treatment Recommendations for Acne-Associated Hyperpigmentation
A group of 10 board-certified dermatologists conducted a Delphi consensus to evaluate the best methods for managing AMH.
Updates from the 2023 AAD Annual Meeting
The 2023 AAD Annual Meeting was buzzing with exciting news and breakthrough studies. Check out some of the latest clinical…
FDA To Review Supplemental Biologics Application for Dupixent for Chronic Spontaneous Urticaria
FDA to review supplemental Biologics License Application for Dupixent® (dupilumab) for chronic spontaneous urticaria (CSU).
Natasha Mesinkovska, MD, PhD Shares Her Pearls on Alopecia Areata
The LiVDerm team caught up with Natasha A. Mesinkovska, MD, PhD at the 2023 SBS to chat about one of…
Suneel Chilukuri, MD on the Latest Cosmetic Devices and Upcoming SBS: West Coast Derm
LiVDerm was honored to speak with Suneel Chilukuri, MD at the 2023 SBS Meeting where he shared his insights on…
Latanya T. Benjamin, MD Named President Elect of Women’s Dermatologic Society
Latanya T. Benjamin, MD has officially been named President-Elect of the Women’s Dermatologic Society.
A Full Recap of Day Two of MOPD 2023
A full recap of Day Two of the 2023 Masters of Pediatric Dermatology Symposium presented by leading industry experts.
New Groundbreaking Study on Acne Antibiotics
Recent study examines how sarecycline works differently from broad-spectrum antibiotics and how this can be used for future treatments.
A Full Recap of Day One of MOPD 2023
A full recap of the 2023 Masters of Pediatric Dermatology Symposium, the incredible two-day event which took place in Miami…
LivDerm Podcasts
Updates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD
Nuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MD
Navigating the Expanding Treatment Landscape for Pediatric Patients with Atopic Dermatitis
Pearls for Early and Accurate Diagnosis of Infantile Atopic Dermatitis
Improving Communication and Shared Decision-Making with Caregivers of Patients with Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Dermatologic Care in the Sexual and Gender Diverse Patient with Klint Peebles, MD
The Latest Advances in Cosmetic Dermatology with Doris J. Day, MD
The Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAAD
Anatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MD
Finding the Fountain of Youth: How Light Keeps Your Skin Glowing
Connect With Us
Looking for more information on our educational opportunities? Please fill out the form below to be contacted by one of our education advisors.
